e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Biomarkers of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Plasma endocan is over-expressed in AECOPD patients: association with lung function decline and apoptosis
L. Dai (Chengdu, China), L. Lian (Chengdu, China), T. Wang (Chengdu, China), D. Xu (Chengdu, China), F. Wen (Chengdu, China)
Source:
International Congress 2018 – Biomarkers of COPD
Session:
Biomarkers of COPD
Session type:
Thematic Poster
Number:
4064
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Dai (Chengdu, China), L. Lian (Chengdu, China), T. Wang (Chengdu, China), D. Xu (Chengdu, China), F. Wen (Chengdu, China). Late Breaking Abstract - Plasma endocan is over-expressed in AECOPD patients: association with lung function decline and apoptosis. 4064
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Late Breaking Abstract - Hypoxia-induced cellular responses in lung fibroblasts from COPD patients and controls
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020
Late Breaking Abstract - Correlation of sputum microRNA-144 expression levels with treatment response among pulmonary tuberculosis patients
Source: International Congress 2018 – New developments in tuberculosis
Year: 2018
Alterations in gene expression of RAGE and its sheddases in blood of COPD patients do not relate to decreased plasma (e)sRAGE levels
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Late Breaking Abstract - Elevated growth differentiation factor 15 in serum correlated with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings
Year: 2019
Late Breaking Abstract - Endobronchial gene-expression clustering in COPD identifies a subgroup with higher level of lymphocytes and accelerated lung function decline
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
Late Breaking Abstract - Plasma cells and endothelitis in COVID-19 lung pathology
Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Year: 2020
Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference?
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Late Breaking Abstract: FAM13A gene confers reduced risk of COPD and lung cancer in current and former smokers
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Late Breaking Abstract - Prognostic value of serum biomarkers in patients with idiopathic pulmonary fibrosis and correlation with disease progression.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Late Breaking Abstract - Association of lung clearance index with survival in patients with cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019
Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
Late Breaking Abstract - Decreased thrombospondin-1 and bone morphogenetic protein-4 serum levels in non-small-cell lung cancer and the relationship of these proteins with the stage of the disease.
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Relationship between plasma amino acid levels and lung function decline in patients with COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Late Breaking Abstract - Roles for transglutaminases in normal and aberrant lung development associated with BPD.
Source: International Congress 2017 – Late-breaking findings in pulmonary diseases
Year: 2017
Late Breaking Abstract - Caveolin-1 derived peptide LTI-03 promotes epithelial cell survival and attenuates pulmonary fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
Late Breaking Abstract - B cells are not involved in the regulation of adenoviral TGF-ß1- or bleomycin-induced lung fibrosis in mice
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021
Late Breaking Abstract - ACE2 expression in lower airway epithelial cells is increased with age and in males, but is less in asthma.
Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Year: 2020
Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD.
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept